281 related articles for article (PubMed ID: 30122362)
1. Systems analysis of human vaccine adjuvants.
Harandi AM
Semin Immunol; 2018 Oct; 39():30-34. PubMed ID: 30122362
[TBL] [Abstract][Full Text] [Related]
2. Correlates of adjuvanticity: A review on adjuvants in licensed vaccines.
Del Giudice G; Rappuoli R; Didierlaurent AM
Semin Immunol; 2018 Oct; 39():14-21. PubMed ID: 29801750
[TBL] [Abstract][Full Text] [Related]
3. Correlates of GLA family adjuvants' activities.
Reed SG; Carter D; Casper C; Duthie MS; Fox CB
Semin Immunol; 2018 Oct; 39():22-29. PubMed ID: 30366662
[TBL] [Abstract][Full Text] [Related]
4. Comparative Systems Analyses Reveal Molecular Signatures of Clinically tested Vaccine Adjuvants.
Olafsdottir TA; Lindqvist M; Nookaew I; Andersen P; Maertzdorf J; Persson J; Christensen D; Zhang Y; Anderson J; Khoomrung S; Sen P; Agger EM; Coler R; Carter D; Meinke A; Rappuoli R; Kaufmann SH; Reed SG; Harandi AM
Sci Rep; 2016 Dec; 6():39097. PubMed ID: 27958370
[TBL] [Abstract][Full Text] [Related]
5. Molecular signatures of vaccine adjuvants.
Olafsdottir T; Lindqvist M; Harandi AM
Vaccine; 2015 Sep; 33(40):5302-7. PubMed ID: 25989447
[TBL] [Abstract][Full Text] [Related]
6. Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity.
Shi S; Zhu H; Xia X; Liang Z; Ma X; Sun B
Vaccine; 2019 May; 37(24):3167-3178. PubMed ID: 31047671
[TBL] [Abstract][Full Text] [Related]
7. An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants.
Fox CB; Haensler J
Expert Rev Vaccines; 2013 Jul; 12(7):747-58. PubMed ID: 23885820
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among children.
Stassijns J; Bollaerts K; Baay M; Verstraeten T
Vaccine; 2016 Feb; 34(6):714-22. PubMed ID: 26740250
[TBL] [Abstract][Full Text] [Related]
9. Analytical Characterization of an Oil-in-Water Adjuvant Emulsion.
Sun J; Remmele RL; Sanyal G
AAPS PharmSciTech; 2017 Jul; 18(5):1595-1604. PubMed ID: 27628187
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005(H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial.
Schuind A; Segall N; Drame M; Innis BL
J Infect Dis; 2015 Aug; 212(4):531-41. PubMed ID: 25722291
[TBL] [Abstract][Full Text] [Related]
11. Adjuvants in influenza vaccines.
Tetsutani K; Ishii KJ
Vaccine; 2012 Dec; 30(52):7658-61. PubMed ID: 23084848
[TBL] [Abstract][Full Text] [Related]
12. Vaccine adjuvants: the dream becomes real.
Tagliabue A; Rappuoli R
Hum Vaccin; 2008; 4(5):347-9. PubMed ID: 18682690
[TBL] [Abstract][Full Text] [Related]
13. Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity.
Marciani DJ
Drug Discov Today; 2003 Oct; 8(20):934-43. PubMed ID: 14554157
[TBL] [Abstract][Full Text] [Related]
14. Vaccine adjuvant activity of emulsified oils from species of the Pinaceae family.
Fox CB; Van Hoeven N; Granger B; Lin S; Guderian JA; Hartwig A; Marlenee N; Bowen RA; Soultanov V; Carter D
Phytomedicine; 2019 Nov; 64():152927. PubMed ID: 31465981
[TBL] [Abstract][Full Text] [Related]
15. The Safety of Adjuvanted Vaccines Revisited: Vaccine-Induced Narcolepsy.
Ahmed SS; Montomoli E; Pasini FL; Steinman L
Isr Med Assoc J; 2016; 18(3-4):216-20. PubMed ID: 27228647
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles.
O'Hagan DT; Ott GS; Van Nest G
Mol Med Today; 1997 Feb; 3(2):69-75. PubMed ID: 9060004
[TBL] [Abstract][Full Text] [Related]
17. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.
Khurana S; Chearwae W; Castellino F; Manischewitz J; King LR; Honorkiewicz A; Rock MT; Edwards KM; Del Giudice G; Rappuoli R; Golding H
Sci Transl Med; 2010 Jan; 2(15):15ra5. PubMed ID: 20371470
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle vaccines against viral infections.
Sulczewski FB; Liszbinski RB; Romão PRT; Rodrigues Junior LC
Arch Virol; 2018 Sep; 163(9):2313-2325. PubMed ID: 29728911
[TBL] [Abstract][Full Text] [Related]
19. Formulation Design, Optimization and In Vivo Evaluations of an α-Tocopherol-Containing Self-Emulsified Adjuvant System using Inactivated Influenza Vaccine.
Lodaya RN; Kanitkar AP; Friedrich K; Henson D; Yamagata R; Nuti S; Mallett CP; Bertholet S; Amiji MM; O'Hagan DT
J Control Release; 2019 Dec; 316():12-21. PubMed ID: 31678654
[TBL] [Abstract][Full Text] [Related]
20. IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants.
Desbien AL; Dubois Cauwelaert N; Reed SJ; Bailor HR; Liang H; Carter D; Duthie MS; Fox CB; Reed SG; Orr MT
J Immunol; 2016 Dec; 197(11):4351-4359. PubMed ID: 27794001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
